Abstract
Artificial OrgansVolume 27, Issue 9 p. 755-758 Pure Red Cell Aplasia Secondary to Treatment with Erythropoietin Francesco Locatelli, Francesco Locatelli Department of Nephrology and Dialysis Ospedale A. Manzoni Lecco, Italy Search for more papers by this authorLucia Del Vecchio, Lucia Del Vecchio Department of Nephrology and Dialysis Ospedale A. Manzoni Lecco, Italy Search for more papers by this author Francesco Locatelli, Francesco Locatelli Department of Nephrology and Dialysis Ospedale A. Manzoni Lecco, Italy Search for more papers by this authorLucia Del Vecchio, Lucia Del Vecchio Department of Nephrology and Dialysis Ospedale A. Manzoni Lecco, Italy Search for more papers by this author First published: 28 August 2003 https://doi.org/10.1046/j.1525-1594.2003.00991.xCitations: 10Read the full textAboutRelatedInformationPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessClose modalShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume27, Issue9September 2003Pages 755-758 RelatedInformation RecommendedProlonged course of pure red cell aplasia after erythropoietin therapyL. Nigg, U. Schanz, P. M. Ambühl, J. Fehr, E. B. Bachli, European Journal of HaematologyPure red‐cell aplasia caused by the antibody to recombinant erythropoietin, epoetin‐β, in a Japanese patient with chronic renal failureKenji Shinohara, Noriyuki Mitani, Mutsuko Miyazaki, Shizu Sakuragi, Kazuyuki Matsuda, Satoru Ogawara, Takao Saito, Hidetoshi Kaneoka, Toshiharu Ooji, American Journal of HematologyErythropoietin-induced, antibody-mediated pure red cell aplasiaThe Pure Red Cell Aplasia Global Scientific Advisory Board (GSAB), European Journal of Clinical InvestigationAcquired pure red cell aplasia: updated review of treatmentKenichi Sawada, Naohito Fujishima, Makoto Hirokawa, British Journal of HaematologyRecovery of pure red‐cell aplasia secondary to antierythropoietin antibodies after cessation of recombinant human erythropoietinU. Panchapakesan, S. K. Austin, A. Shafransky, J. A. Lawrence, E. Savdie, Internal Medicine Journal
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
